This website contains forward-looking statements concerning Sauvie that involve a number of risks and uncertainties. For this purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “plans,” “expects,” “estimates,” “intends,” “should,” “could,” “will,” “may,” “designed,” and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Sauvie’s actual results to differ materially from those indicated by such forward-looking statements, including whether products based on Sauvie’s technology will advance into or through the clinical trial process on a timely basis or at all and receive approval from the United States Food and Drug Administration or equivalent foreign regulatory agencies; whether the Company will complete enrollment of clinical trials or announce trial results in the time expected; whether, if the Company’s products receive approval, they will be successfully distributed and marketed; whether the results of pre-clinical studies will be indicative of results that may be obtained in clinical trials; whether the Company’s collaborations will be successful; whether the patents and patent applications owned or licensed by Sauvie will protect the Company’s technology and prevent others from infringing it; whether Sauvie’s cash resources will be sufficient to fund product development and clinical trials; and such other important factors as are set forth under the caption “Risk Factors” in Sauvie’s most recent presentations which important factors are incorporated herein by reference. Sauvie disclaims any intention or obligation to update any forward-looking statements.